The Canadian Cancer Society (CCS) is issuing a special call for grant applications focused on rare and aggressive uterine cancers, with an emphasis on uterine carcinosarcoma in particular. As a result of a generous donation, there is funding available to support one meritorious application that will impact our understanding of uterine carcinosarcoma and other aggressive uterine cancers, particularly as it relates to the prevention, early detection, diagnosis, and/or treatment of these hard-to-treat cancers.
Eligible types of uterine cancer include:
- Uterine carcinosarcoma
- Serous carcinoma
- Uterine leiomyosarcoma
- Uterine clear cell carcinoma
- Endometrial stromal sarcoma (high-grade)
- Undifferentiated sarcomas
The funding envelope will support a budget of up to $180,000 over 2 years (maximum of $90,000 per year). This grant is renewable for an additional 2 years of funding pending review.
Full applications due: April 6, 2020
Anticipated start date: June 1, 2020
All applications must be submitted through the online application system (EGrAMS) by 5p.m. EST on the deadline date. Submissions will not be accepted beyond these times.